Henry Schein, Inc.
Henry Schein, Inc. (HSIC) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
hsic · pe ratio · data through Dec 27, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Henry Schein, Inc. (HSIC) measures how much investors pay for each dollar of the company's trailing earnings. HSIC's current PE ratio of 22.55x is calculated by dividing its stock price of $77.93 by its TTM earnings per share of $3.44. +5.0% elevated vs 5Y avg 21.5x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-27
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 20 fiscal years · Front-end computedMinQ1 · 25%18.7x
MedianQ3 · 75%23.8x
Max
At 22.55x, HSIC's current P/E is higher than in 80% of its annual fiscal year readings over the past 20 years — historically elevated.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Distribution · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Henry Schein, Inc.You HSIC | $8.9B | 22.55x | +40.4% | $3.44 |
 AptarGroup, Inc. ATR | $7.2B | 20.41x | +27.0% | $5.97 |
 Avantor, Inc. AVTR | $6.7B | N/A | — | -$0.78 |
 Bio-Rad Laboratories, Inc. BIO | $8.0B | 10.87x | -32.4% | $27.87 |
 DaVita Inc. DVA | $12.3B | 13.10x | -18.5% | $8.67 |
 Globus Medical, Inc. GMED | $10.7B | 21.94x | +36.5% | $3.98 |
 Grifols, S.A. GRFS | $6.2B | 14.03x | -12.7% | $0.57 |
Industry Average 5 peers with valid PE | — | 16.07x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-27Latest FY2025 | 23.11x | $3.29 | +0.9% | |
2024-12-28 FY2024 | 22.89x | $3.08 | -3.7% | |
2023-12-31 FY2023 | 23.77x | $3.18 | +17.7% | |
2022-12-31 FY2022 | 20.20x | $3.95 | +16.0% | |
2021-12-31 FY2021 | 17.41x | $4.45 | -26.5% | |
2020-12-31 FY2020 | 23.69x | $2.82 | +22.0% | |
2019-12-31 FY2019 | 19.42x | $3.44 | +10.7% | |
2018-12-31 FY2018 | 17.54x | $3.51 | -18.9% | |
2017-12-31 FY2017 | 21.63x | $2.59 | +14.9% | |
2016-12-31 FY2016 | 18.83x | $3.16 | -12.2% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Henry Schein, Inc. (HSIC) measures how much investors pay for each dollar of the company's trailing earnings. HSIC's current PE ratio of 22.55x is calculated by dividing its stock price of $77.93 by its TTM earnings per share of $3.44.
Frequently asked questions
HSIC pe ratio · 6 questionsHSIC's current PE ratio is 22.55x as of 2026-06-08, based on a stock price of $77.93 and TTM EPS of $3.44. Data sourced from Financial Modeling Prep via HSIC's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Henry Schein, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08